PT  - JOURNAL ARTICLE
AU  - Kuznar, Wayne
ED  - Riddle, Matthew C.
TI  - New Insulin Glargine Formulation Associated with Less Nocturnal Hypoglycemia
DP  - 2013 Dec 01
TA  - MD Conference Express
PG  - 25--26
VI  - 13
IP  - 17
4099  - http://mdc.sagepub.com/content/13/17/25.short
4100  - http://mdc.sagepub.com/content/13/17/25.full
AB  - A long-acting basal insulin glargine formulation, 300 U/mL (Gla-300), controlled glycemia as well as insulin glargine 100 U/mL (Gla-100) in patients with type 2 diabetes mellitus (T2DM) but with less nocturnal hypoglycemia. This article presents findings from a Phase 3 multicenter, open-label [EDITION I; NCT01499082] study comparing the two insulin glargine formulations in patients with T2DM who were using basal plus mealtime insulin.